Literature DB >> 27153926

Stat3 Controls Tubulointerstitial Communication during CKD.

Frank Bienaimé1,2, Mordi Muorah1, Lucie Yammine1, Martine Burtin1, Clément Nguyen1, Willian Baron1, Serge Garbay3, Amandine Viau1, Mélanie Broueilh1, Thomas Blanc1, Dorien Peters4, Valeria Poli5, Dany Anglicheau1,6, Gérard Friedlander1,2, Marco Pontoglio3, Morgan Gallazzini1, Fabiola Terzi7.   

Abstract

In CKD, tubular cells may be involved in the induction of interstitial fibrosis, which in turn, leads to loss of renal function. However, the molecular mechanisms that link tubular cells to the interstitial compartment are not clear. Activation of the Stat3 transcription factor has been reported in tubular cells after renal damage, and Stat3 has been implicated in CKD progression. Here, we combined an experimental model of nephron reduction in mice from different genetic backgrounds and genetically modified animals with in silico and in vitro experiments to determine whether the selective activation of Stat3 in tubular cells is involved in the development of interstitial fibrosis. Nephron reduction caused Stat3 phosphorylation in tubular cells of lesion-prone mice but not in resistant mice. Furthermore, specific deletion of Stat3 in tubular cells significantly reduced the extent of interstitial fibrosis, which correlated with reduced fibroblast proliferation and matrix synthesis, after nephron reduction. Mechanistically, in vitro tubular Stat3 activation triggered the expression of a specific subset of paracrine profibrotic factors, including Lcn2, Pdgfb, and Timp1. Together, our results provide a molecular link between tubular and interstitial cells during CKD progression and identify Stat3 as a central regulator of this link and a promising therapeutic target.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Cell Signaling; Pathophysiology of Renal Disease and Progression; chronic kidney disease; renal fibrosis; renal tubular epithelial cells; transcriptional profiling

Mesh:

Substances:

Year:  2016        PMID: 27153926      PMCID: PMC5118479          DOI: 10.1681/ASN.2015091014

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  65 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  TGF-alpha mediates genetic susceptibility to chronic kidney disease.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Carla Martino; Evangeline Pillebout; Xavier Montagutelli; Gérard Friedlander; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

3.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

Authors:  K Takeda; K Noguchi; W Shi; T Tanaka; M Matsumoto; N Yoshida; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.

Authors:  Wouter N Leonhard; Annemieke van der Wal; Zlata Novalic; Steven J Kunnen; Ron T Gansevoort; Martijn H Breuning; Emile de Heer; Dorien J M Peters
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-23

5.  Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis.

Authors:  R A Risdon; J C Sloper; H E De Wardener
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

6.  Suppressors of cytokine signaling abrogate diabetic nephropathy.

Authors:  Guadalupe Ortiz-Muñoz; Virginia Lopez-Parra; Oscar Lopez-Franco; Paula Fernandez-Vizarra; Beñat Mallavia; Claudio Flores; Ana Sanz; Julia Blanco; Sergio Mezzano; Alberto Ortiz; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

7.  Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.

Authors:  Purificación Hernández-Vargas; Oscar López-Franco; Guillermo Sanjuán; Mónica Rupérez; Guadalupe Ortiz-Muñoz; Yusuke Suzuki; Pablo Aguado-Roncero; Gloria Pérez-Tejerizo; Julia Blanco; Jesús Egido; Marta Ruiz-Ortega; Carmen Gómez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2005-04-13       Impact factor: 10.121

Review 8.  STAT3 as a central mediator of neoplastic cellular transformation.

Authors:  David A Frank
Journal:  Cancer Lett       Date:  2006-11-28       Impact factor: 8.679

9.  Origin and function of myofibroblasts in kidney fibrosis.

Authors:  Valerie S LeBleu; Gangadhar Taduri; Joyce O'Connell; Yingqi Teng; Vesselina G Cooke; Craig Woda; Hikaru Sugimoto; Raghu Kalluri
Journal:  Nat Med       Date:  2013-06-30       Impact factor: 53.440

Review 10.  Novel targets of antifibrotic and anti-inflammatory treatment in CKD.

Authors:  Anne-Emilie Declèves; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2014-03-25       Impact factor: 28.314

View more
  40 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 2.  Targeting STAT3 signaling in kidney disease.

Authors:  Jesse Pace; Praharshasai Paladugu; Bhaskar Das; John C He; Sandeep K Mallipattu
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

3.  Proximal Tubule Translational Profiling during Kidney Fibrosis Reveals Proinflammatory and Long Noncoding RNA Expression Patterns with Sexual Dimorphism.

Authors:  Haojia Wu; Chun-Fu Lai; Monica Chang-Panesso; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2019-09-19       Impact factor: 10.121

4.  Beyond EMT: Epithelial STAT3 as a Central Regulator of Fibrogenesis.

Authors:  Jeremy S Duffield
Journal:  J Am Soc Nephrol       Date:  2016-07-01       Impact factor: 10.121

5.  Krüppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation.

Authors:  Chelsea C Estrada; Praharshasai Paladugu; Yiqing Guo; Jesse Pace; Monica P Revelo; David J Salant; Stuart J Shankland; Vivette D D'Agati; Anita Mehrotra; Stephanie Cardona; Agnieszka B Bialkowska; Vincent W Yang; John C He; Sandeep K Mallipattu
Journal:  JCI Insight       Date:  2018-06-21

Review 6.  The third path of tubulointerstitial fibrosis: aberrant endothelial secretome.

Authors:  Mark Lipphardt; Jong W Song; Kei Matsumoto; Sina Dadafarin; Hassan Dihazi; Gerhard Müller; Michael S Goligorsky
Journal:  Kidney Int       Date:  2017-05-03       Impact factor: 10.612

Review 7.  Progression of chronic kidney disease: too much cellular talk causes damage.

Authors:  Leslie Gewin; Roy Zent; Ambra Pozzi
Journal:  Kidney Int       Date:  2016-10-20       Impact factor: 10.612

8.  Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis.

Authors:  Janet Y Leung; Harper L Wilson; Kristin J Voltzke; Lindsay A Williams; Hyo Jin Lee; Sara E Wobker; William Y Kim
Journal:  Mol Cell Biol       Date:  2017-05-31       Impact factor: 4.272

9.  Heme oxygenase-2 protects against ischemic acute kidney injury: influence of age and sex.

Authors:  Karl A Nath; Vesna D Garovic; Joseph P Grande; Anthony J Croatt; Allan W Ackerman; Gianrico Farrugia; Zvonimir S Katusic; John D Belcher; Gregory M Vercellotti
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-19

10.  Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.

Authors:  Yunhe Zhang; Jianan Zou; Evelyn Tolbert; Ting C Zhao; George Bayliss; Shougang Zhuang
Journal:  FASEB J       Date:  2020-04-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.